IDEAYA Biosciences filed a new automatic shelf registration statement on Form S-3ASR to replace the expiring prior registration, maintaining $156.6 million capacity for common stock sales under its existing Sales Agreement with Jefferies.
Key takeaways
Filed New Registration Statement (No. 333-295560) on May 5, 2026, replacing Prior Registration Statement (No. 333-272936) expiring June 26, 2026.
Prior Registration Statement terminated per Rule 415(a)(6) upon new filing effectiveness.
Filed ATM Prospectus Supplement to New Registration Statement under January 19, 2024 Sales Agreement with Jefferies.
$156,552,996.81 remains available for common stock sales after $193,447,003.19 previously sold.
Latham & Watkins LLP issued opinion (Exhibit 5.1) on validity of shares issuable under ATM Prospectus Supplement.